Industry: MED - PRODUCTS Closing Price: 36.56 P/E: 19.18 Avg. Vol.: 5,516K

Company Profile: Medtronic is the world's leading medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Primary products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries.

Objective: Income Strategy with consideration for Accumulated Income

Trade: BUY the NOV 37.50 CALLS and SELL the SEP 37 CALLS (Diagonal Spread) for a Debit of at or near .72

Entry Target: MDT above 36.50